Solvay reports that it has expanded its range of filaments for additive manufacturing (AM) applications.
The company has introduced three medical grade products for use in the healthcare industry; KetaSpire polyetheretherketone (PEEK) AM filament (NT1 HC), a 10% carbon fiber reinforced KetaSpire PEEK AM filament (CF10 HC), and Rade® polyphenylsulfone (PPSU) AM filament (NT1 HC) which are suitable for limited contact applications (<24hr bodily fluid/tissue contact).
‘The healthcare industry is quickly emerging as a leading market to benefit from AM technology which makes customized parts for single use or low volumes possible,’ said Christophe Schramm, AM business manager at Solvay Specialty Polymers. ’However, there is still a very limited choice of high-performance filaments that meet the stringent regulatory requirements in healthcare and this is the gap we want to close with our new selection of medical grade products.’
The company’s KetaSpire PEEK AM filaments reportedly offer improved fusion of printed layers, high part density and improved part strength, including along the z-axis.
This story is reprinted from material from Solvay, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
